Senior insider sale
Senior Vice President, R&D at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$13.04M
209.05K shares
What this filing means
ROTE WILLIAM E. plans to sell 209.05K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $13.04M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/16/2026ACC: 0001950047-26-009577
Officer· Senior Vice President, R&D
Since Nov 2018
209.05K
Shares to sell
$13.04M
Approx. market value
112.85K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
9/16/2026
112.85KTotal acquired112.85K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/16/2026 | Exercise of Stock Options Cash | 112.85K | — |
| Total | 112.85K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
96.20K
Market value
$5.99M
9/15/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
112.85K
Market value
$7.05M
9/16/2026
Total
Units
209.05K
Value
$13.04M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/15/2026 | 96.20K | $5.99M | — | Completed |
| Planned — Approximate Date | ||||
9/16/2026 | 112.85K | $7.05M | NASDAQ | Planned |
| Total | 209.05K | $13.04M | ||